{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T05:13:45Z","timestamp":1774070025426,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2014.092.1"],"award-info":[{"award-number":["2014.092.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["MA2530\/6-1"],"award-info":[{"award-number":["MA2530\/6-1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["MA2530\/8-1"],"award-info":[{"award-number":["MA2530\/8-1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["111853"],"award-info":[{"award-number":["111853"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["70112956"],"award-info":[{"award-number":["70112956"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["2014.092.1"],"award-info":[{"award-number":["2014.092.1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MA2530\/6-1"],"award-info":[{"award-number":["MA2530\/6-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["MA2530\/8-1"],"award-info":[{"award-number":["MA2530\/8-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["111853"],"award-info":[{"award-number":["111853"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["70112956"],"award-info":[{"award-number":["70112956"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["2014.092.1"],"award-info":[{"award-number":["2014.092.1"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["MA2530\/6-1"],"award-info":[{"award-number":["MA2530\/6-1"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["MA2530\/8-1"],"award-info":[{"award-number":["MA2530\/8-1"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["111853"],"award-info":[{"award-number":["111853"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70112956"],"award-info":[{"award-number":["70112956"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroscience Methods"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jneumeth.2021.109141","type":"journal-article","created":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T20:12:11Z","timestamp":1616184731000},"page":"109141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Crispr\/Cas-based modeling of NF2 loss in meningioma cells"],"prefix":"10.1016","volume":"356","author":[{"given":"Natalie","family":"Waldt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Kesseler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Fala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmar","family":"Kirches","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Angenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6677-3124","authenticated-orcid":false,"given":"Christian","family":"Mawrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneumeth.2021.109141_bib0005","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1750-3639.2007.00109.x","article-title":"An orthotopic skull base model of malignant meningioma","volume":"18","author":"Baia","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0010","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/ng.2526","article-title":"Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations","volume":"45","author":"Brastianos","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0015","first-page":"1634","article-title":"A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098","volume":"20","author":"Brown","year":"2018","journal-title":"Neurooncology"},{"key":"10.1016\/j.jneumeth.2021.109141_bib0020","first-page":"1634","article-title":"A study of the focal adhesion kinase inhibitor GSK2256098 in patients with recurrent glioblastoma with evaluation of tumor penetration of [11C]GSK2256098","volume":"20","author":"Brown","year":"2018","journal-title":"Neurooncology"},{"key":"10.1016\/j.jneumeth.2021.109141_bib0025","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1126\/science.1233009","article-title":"Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO","volume":"339","author":"Clark","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jneumeth.2021.109141_bib0030","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3651","article-title":"Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas","author":"Clark","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0035","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/sj.bjc.6604002","article-title":"Nf2\/Merlin: a coordinator of receptor signalling and intercellular contact","volume":"98","author":"Curto","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jneumeth.2021.109141_bib0040","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1158\/1078-0432.CCR-10-0891","article-title":"Genomic profiling reveals alternative genetic pathways of meningioma malignant progression dependent on the underlying NF2 status","volume":"16","author":"Goutagny","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1750-3639.2006.tb00557.x","article-title":"NF2 mutations in secretory and other rare variants of meningiomas","volume":"16","author":"Hartmann","year":"2006","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0050","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1128\/MCB.01581-08","article-title":"NF2\/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth","volume":"29","author":"James","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0055","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1158\/1541-7786.MCR-11-0425-T","article-title":"Regulation of mTOR complex 2 signaling in neurofibromatosis 2-deficient target cell types","volume":"10","author":"James","year":"2012","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0060","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1101\/gad.226302","article-title":"Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse","volume":"16","author":"Kalamarides","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0065","article-title":"Historical benchmarks for medical therapy trials in surgery- and radiation-refractory meningioma: a RANO review","author":"Kaley","year":"2014","journal-title":"Neurooncology"},{"key":"10.1016\/j.jneumeth.2021.109141_bib0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semcdb.2019.04.018","article-title":"CRISPR-Cas9: a multifaceted therapeutic strategy for cancer treatment","volume":"96","author":"Kaushik","year":"2019","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0075","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1074\/jbc.M305526200","article-title":"Merlin neutralizes the inhibitory effect of Mdm2 on p53","volume":"279","author":"Kim","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-010-0342-2","article-title":"Pathological classification and molecular genetics of meningiomas","volume":"99","author":"Mawrin","year":"2010","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0085","series-title":"American Society of Clinical Oncology Educational Book \/ ASCO","first-page":"e106","article-title":"Biology and clinical management challenges in meningioma","author":"Mawrin","year":"2015"},{"key":"10.1016\/j.jneumeth.2021.109141_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178322","article-title":"Genomic profile of human meningioma cell lines","volume":"12","author":"Mei","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jneumeth.2021.109141_bib0095","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/13543784.2020.1740680","article-title":"FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials","volume":"29","author":"Mohanty","year":"2020","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.jneumeth.2021.109141_bib0100","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1101\/gad.189601","article-title":"The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44","volume":"15","author":"Morrison","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cancergencyto.2005.04.003","article-title":"Inactivation patterns of NF2 and DAL-1\/4.1B (EPB41L3) in sporadic meningioma","volume":"162","author":"Nunes","year":"2005","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0110","first-page":"iv1","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neurooncology"},{"key":"10.1016\/j.jneumeth.2021.109141_bib0115","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/1078-0432.CCR-12-1904","article-title":"mTORC1 inhibitors suppress meningioma growth in mouse models","volume":"19","author":"Pachow","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/onc.2015.125","article-title":"Role of Merlin\/NF2 inactivation in tumor biology","volume":"35","author":"Petrilli","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jneumeth.2021.109141_bib0125","doi-asserted-by":"crossref","first-page":"32713","DOI":"10.18632\/oncotarget.5296","article-title":"PDGF activation in PGDS-positive arachnoid cells induces meningioma formation in mice promoting tumor progression in combination with Nf2 and Cdkn2ab loss","volume":"6","author":"Peyre","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.jneumeth.2021.109141_bib0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2017.168","article-title":"Advances in meningioma genetics: novel therapeutic opportunities","volume":"14","author":"Preusser","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0135","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng0294-180","article-title":"Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas","volume":"6","author":"Ruttledge","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0140","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1073\/pnas.84.15.5419","article-title":"Molecular genetic approach to human meningioma: loss of genes on chromosome 22","volume":"84","author":"Seizinger","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0145","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2014.04.044","article-title":"Analyses of merlin\/NF2 connection to FAK inhibitor responsiveness in serous ovarian cancer","volume":"134","author":"Shah","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0150","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008639","article-title":"Merlin Deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship","volume":"6","author":"Shapiro","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1750-3639.2005.tb00095.x","article-title":"Reduced apoptosis rates in human schwannomas","volume":"15","author":"Utermark","year":"2005","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s40478-020-00912-x","article-title":"KLF4(K409Q)-mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment","volume":"8","author":"von Spreckelsen","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0165","first-page":"827","article-title":"Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma","volume":"146","author":"Wellenreuther","year":"1995","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0170","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00432-014-1683-6","article-title":"Re-evaluation of cytostatic therapies for meningiomas in vitro","volume":"140","author":"Wilisch-Neumann","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jneumeth.2021.109141_bib0175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2741\/4817","article-title":"NF2\/Merlin suppresses proliferation and induces apoptosis in colorectal cancer cells","volume":"25","author":"Wu","year":"2020","journal-title":"Front. Biosci. Landmark Ed. (Landmark Ed)"},{"key":"10.1016\/j.jneumeth.2021.109141_bib0180","article-title":"Associations of meningioma molecular subgroup and tumor recurrence","author":"Youngblood","year":"2020","journal-title":"Neurooncology"}],"container-title":["Journal of Neuroscience Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027021000765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165027021000765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:56:10Z","timestamp":1759020970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165027021000765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":36,"alternative-id":["S0165027021000765"],"URL":"https:\/\/doi.org\/10.1016\/j.jneumeth.2021.109141","relation":{},"ISSN":["0165-0270"],"issn-type":[{"value":"0165-0270","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crispr\/Cas-based modeling of NF2 loss in meningioma cells","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroscience Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneumeth.2021.109141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109141"}}